Peptobiotics, a Singaporean synthetic biology startup, is positioned at the intersection of agriculture and biotechnology. Founded in 2020, the company specializes in livestock disease prevention and aims to enhance sustainable agricultural productivity. Backed by EF Venture Capital, Peptobiotics operates from its headquarters in Singapore.
The company recently secured a $6.20M Series A investment on 09 April 2024, underscoring its growth trajectory and potential. The funding round was supported by a diverse group of investors, including Seventure Partners, Trendlines Group, Ponderosa Ventures, SEEDS Capital, Hatch Blue, The Yield Lab Asia Pacific, GrainCorp Ventures, and Farmabase. Peptobiotics' focus on merging cutting-edge science with practical agricultural applications positions it as a promising player in the agri-tech sector, particularly for those investors seeking to drive innovation in sustainable food production.